News

The drug, called Yeztugo from company Gilead Sciences, was approved Wednesday based on data from clinical trials that showed 99.9% of participants who received it remained HIV negative.
Spring has sprung—and so have the fails! From backyard bloopers to egg hunts gone wrong, this seasonal special features the best fails of spring.
Saia doesn’t provide any revenue-based metrics in its intraquarter updates. During the first quarter, yields were negative (down 5.1% y/y excluding fuel surcharges). Heavier shipment weights were a ...